Abbott (ABT) Tops Q1 EPS by 7c, Revenue Beats, Suspends Guidance
Tweet
Share
E-mail
Get Alerts ABT Hot Sheet
Price: $87.83 -0.66%
EPS Growth %: +1.6%
Financial Fact:
Research and development: 352M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +1.6%
Financial Fact:
Research and development: 352M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Abbott (NYSE: ABT) reported Q1 EPS of $0.65, $0.07 better than the analyst estimate of $0.58. Revenue for the quarter came in at $7.7 billion versus the consensus estimate of $7.34 billion.
Due to uncertainties regarding the duration and impact of the coronavirus (COVID-19) pandemic, Abbott is suspending its previously announced annual guidance for 2020.
For earnings history and earnings-related data on Abbott (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Ridgepost Capital acquires Stellus Capital Management for $4B AUM
- Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
